Author

M. L. Kemp

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Assay:metabolomics· 2 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Assay:imaging· 1

Frequent Co-Authors

A. A. Nikitina· 2 shared A. R. Liversage· 1 shared A. R. Van Grouw· 1 shared A. Van Grouw· 1 shared D. DeRyckere· 1 shared D. Huang· 1 shared D. K. Graham· 1 shared D. Y. Zhang· 1 shared

Activity by Year

2022-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

A. A. Nikitina

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Screening and Development of Constitutively Synergistic Combination Drug Formulations for T Cell Acute Lymphoblastic Leukemia

J. M. Kelvin, D. Y. Zhang, E. K. Williams, S. G. Moore, L. A. Birnbaum, H. Zecca, X. Wang, J. Jain, M. Qui, N. T. Jui, H. Fu, Y. Du, M. L. Kemp, W. A. Lam, D. DeRyckere, , E. C. Dreaden

The paper identifies synergistic drug combinations for T-ALL using high-throughput screens and develops lipid nanoparticle formulations that maintain drug synergy and improve anti-leukemic activity.

bioRxiv · Sep 21, 2022 · PreprintBioengineering

Mass spectrometry imaging reveals early metabolic priming of cell lineage in differentiating human induced pluripotent stem cells

A. A. Nikitina, A. Van Grouw, T. Roysam, D. Huang, F. M. Fernandez, M. L. Kemp

The paper uses mass spectrometry imaging to identify metabolic markers of lineage specification in differentiating human iPSCs, showing phospholipids as early indicators of pluripotency loss.

bioRxiv · Aug 16, 2022Bioengineering

Integration of imaging modalities with lipidomic characterization to investigate MSCs potency metrics

L. J. Mortensen, P. Priyadarshani, A. R. Van Grouw, A. R. Liversage, A. A. Nikitina, K. F. Tehrani, M. L. Kemp, F. Fernandez

The paper investigates MSCs potency by integrating imaging and lipidomic data to correlate lipid signaling with phenotypic changes and subpopulation heterogeneity.

bioRxiv · May 25, 2022 · PreprintCell Biology